Related references
Note: Only part of the references are listed.Parkinson's Disease-Related Biomarkers That May Appear in Amphetamine Abusers
Aziza Al-Rafiah et al.
BIOMED RESEARCH INTERNATIONAL (2021)
Pigment Epithelium-Derived Factor Improves Paracellular Blood-Brain Barrier Integrity in the Normal and Ischemic Mouse Brain
Arina Riabinska et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2020)
The Impact of Natural Compounds on the Treatment of Neurodegenerative Diseases
Lorane I. da S. Hage-Melim et al.
CURRENT ORGANIC CHEMISTRY (2019)
Chemokines in Alzheimer's Disease: New Insights Into Prokineticins, Chemokine-Like Proteins
Anna Rita Zuena et al.
FRONTIERS IN PHARMACOLOGY (2019)
Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers
Kwangsik Nho et al.
JAMA NETWORK OPEN (2019)
Current Limitations in the Treatment of Parkinson's and Alzheimer's Diseases: State-of-the-Art and Future Perspective of Polymeric Carriers
Chiara Tonda-Turo et al.
CURRENT MEDICINAL CHEMISTRY (2018)
Inflammasome Activation by Methamphetamine Potentiates Lipopolysaccharide Stimulation of IL-1 beta Production in Microglia
Enquan Xu et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2018)
Pigment Epithelium-Derived Factor Plays a Role in Alzheimer's Disease by Negatively Regulating Aβ42
Mao Huang et al.
NEUROTHERAPEUTICS (2018)
Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study
Vijay R. Varma et al.
PLOS MEDICINE (2018)
Increased CCL18 plasma levels are associated with neurodegenerative MRI outcomes in multiple sclerosis patients
Nicole Ziliotto et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2018)
Blood-Derived Plasma Protein Biomarkers for Alzheimer's Disease in Han Chinese
Zaohuo Cheng et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Recent Advances in Biomarkers for Parkinson's Disease
Runcheng He et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Pathogenesis of alcoholic liver disease
Kazushi Sugimoto et al.
HEPATOLOGY RESEARCH (2017)
Alzheimer's disease: Elevated pigment epithelium-derived factor in the cerebrospinal fluid is mostly of systemic origin
Veronika Lang et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2017)
The Role of Oxidative Stress in Methamphetamine-induced Toxicity and Sources of Variation in the Design of Animal Studies
Kate McDonnell-Dowling et al.
CURRENT NEUROPHARMACOLOGY (2017)
Midkine Is a Novel Regulator of Amphetamine-Induced Striatal Gliosis and Cognitive Impairment: Evidence for a Stimulus-Dependent Regulation of Neuroinflammation by Midkine
Marta Vicente-Rodriguez et al.
MEDIATORS OF INFLAMMATION (2016)
Association between alcohol and Alzheimer's disease
Wen-Juan Huang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2016)
PEDF and its roles in physiological and pathological conditions: implication in diabetic and hypoxia-induced angiogenic diseases
Xuemin He et al.
CLINICAL SCIENCE (2015)
Clinical epidemiology of Alzheimer's disease: assessing sex and gender differences
Michelle M. Mielke et al.
CLINICAL EPIDEMIOLOGY (2014)
2013 Alzheimer's disease facts and figures Alzheimer's Association
William Thies et al.
ALZHEIMERS & DEMENTIA (2013)
Plasma Levels of Complement 4a Protein are Increased in Alzheimer's Disease
Stuart Bennett et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2012)
Effects of hemochromatosis and transferrin gene mutations on iron dyshomeostasis, liver dysfunction and on the risk of Alzheimer's disease
Federica Giambattistelli et al.
NEUROBIOLOGY OF AGING (2012)
Drug dependence and psychotic symptoms: a retrospective study of adolescents who abuse drugs at Al-Amal Hospital in Jeddah, Saudi Arabia
Osama Alibrahim et al.
JOURNAL OF PUBLIC HEALTH IN AFRICA (2012)
Increased Serum Levels of Pigment Epithelium-Derived Factor by Excessive Alcohol Consumption-Detection and Identification by a Three-Step Serum Proteome Analysis
Kazuyuki Sogawa et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2011)
Combined measurement of PEDF, haptoglobin and tau in cerebrospinal fluid improves the diagnostic discrimination between alzheimer's disease and other dementias
Jean-Daniel Abraham et al.
BIOMARKERS (2011)
Neurologic Manifestations of Chronic Methamphetamine Abuse
Daniel E. Rusyniak
NEUROLOGIC CLINICS (2011)
Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease
Alex E. Roher et al.
BIOMARKERS (2009)
Gene transfer of PEDF attenuates ischemic brain damage in the rat middle cerebral artery occlusion model
Tomomi Sanagi et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Microglial dysfunction and defective β-amyloid clearance pathways in aging Alzheimer's disease mice
Suzanne E. Hickman et al.
JOURNAL OF NEUROSCIENCE (2008)
Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons
Jaya Padmanabhan et al.
BRAIN (2006)
Is pigment epithelium-derived factor level in cerebrospinal fluid a promising biomarker for early diagnosis of Alzheimer's disease
S Yamagishi et al.
MEDICAL HYPOTHESES (2004)
α-1-Antichymotrypsin promotes β-sheet amyloid plaque deposition in a transgenic mouse model of Alzheimer's disease
LNG Nilsson et al.
JOURNAL OF NEUROSCIENCE (2001)
Share Paper
